Cardio-Oncology and Reverse Cardio-Oncology: the Manifold Interconnections Between Heart Failure and Cancer

  • 9,110

    Total Downloads

  • 31k

    Total Views and Downloads

Submit your idea

Select the journal/section where you want your idea to be submitted:

Submit your manuscript summarySubmit your manuscript

About this Research Topic

Submission closed

Background

This Research Topic is associated with the 36th meeting of the International Society for Heart Research – European Section, 29 June-2 July 2021, Turin (Italy). 
Although cardiovascular disease (CVD) and cancer have long been considered as two distinct entities, increasing evidence supports an intimate interconnection between these two conditions, with one predisposing to the other, with a continuous interplay. The recognition that cancer patients have significantly higher cardiovascular mortality risk than the general population, mostly because of the cardiotoxic side effects of anti-cancer treatments, prompted the development of the “Cardio-Oncology” discipline. The major goal of this branch of cardiology is to understand and tackle cancer therapy-related cardiotoxicity. A novel, exciting frontier of Cardio-Oncology is represented by the so-called “reverse Cardio-Oncology”, which aims at unraveling the mechanisms and the clinical implications behind cancer occurrence in patients with established CVD. This field of research has been stimulated by recent groundbreaking studies, overall converging on the provocative concept that heart failure (HF) implies a predisposition to cancer formation and/or progression. 
Over the last decades, Cardio-Oncology has shed light on the mechanisms by which widely used anti-cancer drugs, such as anthracyclines and anti-HER2 monoclonal antibodies, cause HF, and on the potential cardioprotective effects of molecules such as dexrazoxane. Nevertheless, the molecular events behind the cardiotoxicity of the next generation of oncological treatments, like immune check point inhibitors, are incompletely understood, and new anti-cancer therapies are marketed continuously. These limitations in knowledge prevent from finding specific and effective strategies to diagnose, prevent and treat HF secondary to cancer therapy-related cardiotoxicity. Furthermore, the nascent field of Reverse Cardio-oncology has just started to reveal the biological processes shared by cancer and HF, such as chronic systemic inflammation and clonal hematopoiesis of indeterminate potential. Breakthrough discoveries in this area are expected to pave the way towards repurposing of existing cardiovascular treatments to cure cancer, the use of antineoplastic agents to treat HF and/or the devise of next-generation therapies targeting cancer and HF simultaneously. The purpose of this Research Topic is to address current challenges of Cardio-Oncology and Reverse Cardio-Oncology. Original Research Articles and Reviews focused on but not restricted to the following areas are encouraged:1) Identification of shared mechanisms as well as common risk factors of cancer and HF2) Development of powerful in vitro and in vivo models for the study of the interaction between cancer and HF as well as cardiotoxicity of oncological treatments, especially next generation drugs.3) Dissecting the signaling pathways underlying the cardiotoxicity of most widely used as well as novel anti-cancer treatments4) Understanding the role of intercellular cross-talks in the development of cardiotoxicity5) Identification of new biomarkers and imaging technologies for early diagnosis of cardiotoxicity6) Validating new preclinical approaches/molecules for cardioprotection and cancer prevention 

Prof. Alessandra Ghigo is co-founder and board member of Kither Biotech, a spin-off company focused on the development of PI3K inhibitors for airway diseases not in conflict with the theme of the proposed Research Topic.
Dr. Pietro Ameri received speaker and advisor honoraria from Boehringer Ingelheim, Daiichi Sankyo, Novartis, Astra Zeneca, MSD, GlaxoSmithKline and Janssen. The Department of Internal Medicine of the University of Genova signed contracts with Daiichi Sankyo, Astra Zeneca and Janssen for scientific activity, which was performed by Pietro Ameri.
The other Topic Editors declare no competing interests with regard to the Research Topic subject.

Keywords: Heart failure, cancer, anti-cancer therapies, cardiotoxicity, shared mechanisms

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and they fall under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

      In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

     

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

     

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

     

Participating Journals

Impact

  • 31kTopic views
  • 21kArticle views
  • 9,110Article downloads
View impact